Jeannie-Marie Skinner

Ms. Skinner brings more than 35 years of pharmaceutical industry experience in global regulatory affairs, clinical operations, and strategic drug development. Prior to joining Ashvattha, she was an Executive Director at Syneos Health where she was responsible for the development of strategies, interactions and submissions to the FDA and international health authorities for multiple small and mid-sized pharmaceutical clients. Previously, she worked at Hoffmann-LaRoche, Novartis, Baxalta (now Takeda), MacoPharma and several start-ups where she was responsible for the product registrations and approvals for NDAs, BLAs, ANDAs and INDs. She has worked across diverse therapeutic areas including oncology, neurology, ophthalmology, dermatology, gene therapy, respiratory, rare diseases and infectious diseases. Ms. Skinner holds a B.S. in Medical Technology from Rutgers University, an M.S. in Microbiology from Fairleigh Dickinson University and an MBA from Montclair State University.